Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Pemwel Injection
Pemwel Injection is a targeted chemotherapy agent designed for the treatment of non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM). With Pemetrexed 500mg, it provides effective tumor growth control by interfering with cancer cell metabolism.
Uses of Pemwel Injection
First-line treatment of advanced non-squamous NSCLC in combination with other agents.
Maintenance therapy for NSCLC after initial chemotherapy response.
Effective against malignant pleural mesothelioma in combination with cisplatin.
Provides significant disease control and survival benefits in eligible cancer patients.
Benefits of Pemwel Injection
Clinically proven efficacy in advanced non-squamous NSCLC and MPM.
Inhibits key cancer cell metabolic pathways, reducing tumor progression.
Can be used as both initial therapy and maintenance treatment.
Enhances progression-free survival and overall treatment outcomes.
Administered under strict medical supervision, ensuring patient safety.
Mechanism of Action of Pemwel Injection
Inhibits folate-dependent enzymes, disrupting DNA and RNA synthesis in cancer cells.
Reduces cancer cell proliferation and promotes tumor regression.
Targets specific metabolic pathways, offering focused and effective cancer therapy.
For best results, Pemwel Injection should be used under the guidance of an oncology specialist. Regular monitoring and supportive care, including folic acid and vitamin B12 supplementation, help improve safety and effectiveness. Store and handle the injection according to prescribed protocols.